---
title: "ANKE BIO released its performance for the first three quarters, with a net profit attributable to the parent company of 551 million yuan, a decrease of 6.48%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262934630.md"
description: "According to the Zhitong Finance APP, ANKE BIO released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.963 billion yuan, a year-on-year increase of 2.15%. The net profit attributable to shareholders of the listed company was 551 million yuan, a year-on-year decrease of 6.48%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 519 million yuan, a year-on-year decrease of 6.56%. The basic earnings per share were 0.3297 yuan"
datetime: "2025-10-27T15:33:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262934630.md)
  - [en](https://longbridge.com/en/news/262934630.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262934630.md)
---

# ANKE BIO released its performance for the first three quarters, with a net profit attributable to the parent company of 551 million yuan, a decrease of 6.48%

According to the Zhitong Finance APP, ANKE BIO (300009.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.963 billion yuan, a year-on-year increase of 2.15%. The net profit attributable to shareholders of the listed company was 551 million yuan, a year-on-year decrease of 6.48%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 519 million yuan, a year-on-year decrease of 6.56%. The basic earnings per share were 0.3297 yuan

### Related Stocks

- [300009.CN](https://longbridge.com/en/quote/300009.CN.md)

## Related News & Research

- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [15:55 ETInception Fertility Launches MySpermBank, Expanding Access to Donor Sperm Services Nationwide](https://longbridge.com/en/news/287265370.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [New report highlights gap between New GMO hype and global market reality](https://longbridge.com/en/news/287257766.md)